ASGCT 2026

Cellistic at ASGCT 2026 in Boston | iPSC Cell Therapy CDMO

Cellistic will attend the American Society for Cell & Gene Therapy (ASGCT) Annual Meeting 2026 in Boston, alongside leaders shaping the future of cell and gene therapy.

Connect with our expert on site to discover how Cellistic, as an iPSC-focused CDMO, supports the development and scalable manufacturing of allogeneic cell therapies for immuno-oncology and regenerative medicine.

We will showcase our GMP manufacturing platforms, including:

• Echo™-Cardio for cardiomyocytes
• Echo™-Endothelial for endothelial cells
• Echo™-T for α/β T cells & Tregs
• Echo™-NK for natural killer (NK) cells

Built on 15+ years of iPSC expertise, our platforms accelerate your path to clinic with scalable, cost-effective iPSC-derived solutions. 

We look forward to connecting with drug developers advancing cell therapy programs.

Meet our team

Wesley Tidball will be on site at ASGCT in Boston and available for one-on-one conversations or informal meetings through the conference.